
News|Videos|February 3, 2024
Angiogenesis 2024: The implication of longitudinal AI-based fluid quantification for at-home monitoring
Author(s)Hattie Hayes, Martin David Harp
Anat Loewenstein, MD, sat down with Hattie Hayes of Ophthalmology Times Europe to discuss the implication of longitudinal AI-based fluid quantification for at-home monitoring from the Angiogenesis Exudation and Degeneration 2024 event.
Advertisement
Anat Loewenstein, MD, sat down with Hattie Hayes of Ophthalmology Times Europe to discuss the implication of longitudinal AI-based fluid quantification for at-home monitoring from the Angiogenesis Exudation and Degeneration 2024 event.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
2
Precise Bio completes procedure using PB-001, a 3D-bioprinted corneal implant
3
Corza Medical announces launch of the SensorTek ROP Kit
4
EyePoint receives second consecutive positive recommendation from DSMC
5


















































.png)


